Oruka Therapeutics (ORKA) Operating Expenses (2010 - 2024)
Oruka Therapeutics (ORKA) posted quarterly Operating Expenses of $3.1 million for Q2 2024, up 58.24% year-over-year from $2.0 million in Q3 2023, and up 25.79% quarter-over-quarter from $2.5 million in Q1 2024.
Oruka Therapeutics (ORKA) Operating Expenses (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Operating Expenses history runs 15 years deep, the most recent figure standing at $3.1 million for Q2 2024.
- In Q2 2024, Operating Expenses rose 58.24% year-over-year to $3.1 million; the TTM figure through Mar 2025 stood at $3.1 million (down 60.89% YoY), while the FY2023 annual figure was $7.3 million, down 31.14% from the prior year.
- Operating Expenses for Q2 2024 stood at $3.1 million, up from $2.5 million in the prior quarter.
- The five-year high for Operating Expenses was $5.7 million in Q4 2021, with the low at $1.3 million in Q2 2020.
- The 5-year median for Operating Expenses is $2.5 million (2022), against an average of $2.9 million.
- The sharpest annual moves came in 2020 and 2022: Operating Expenses surged 301.1% in 2020, then plunged 72.75% in 2022.
- Oruka Therapeutics' Operating Expenses stood at $5.1 million in 2020, then advanced by 10.81% to $5.7 million in 2021, then slumped by 72.75% to $1.5 million in 2022, then climbed by 2.71% to $1.6 million in 2023, then soared by 96.35% to $3.1 million in 2024.
- Business Quant data shows ORKA's Operating Expenses at $3.1 million in Q2 2024, $2.5 million in Q1 2024, and $1.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 2.55 Mn |
| Jun 30, 2022 | 3.22 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 5.68 Mn |
| Sep 30, 2021 | 4.72 Mn |
| Jun 30, 2021 | 4.84 Mn |
| Mar 31, 2021 | 4.10 Mn |
| Dec 31, 2020 | 5.13 Mn |
| Sep 30, 2020 | 1.99 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Mar 31, 2020 | 1.34 Mn |
| Dec 31, 2019 | 1.28 Mn |
| Sep 30, 2019 | 1.25 Mn |